US Stock MarketDetailed Quotes

ESLA Estrella Immunopharma

Watchlist
  • 0.740
  • -0.061-7.62%
Close Nov 8 16:00 ET
26.78MMarket Cap-3681P/E (TTM)

Estrella Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1,102.61%-16.07M
-574.10%-291.51K
-4,914.13%-4.23M
-10,313.48%-11.27M
74.99%-275.19K
7.34%-1.34M
95.33%-43.25K
21.30%-84.45K
-108.2K
-1.1M
Net income from continuing operations
34.21%-7.31M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
---2.76M
---2.89M
Depreciation and amortization
----
----
--0
----
----
----
----
--5.49K
----
----
Change In working capital
-206.22%-9.95M
40.73%3.66M
-247.72%-3.77M
-503.91%-10.25M
-76.19%400.65K
8,165.20%9.37M
2,194.06%2.6M
--2.55M
--2.54M
--1.68M
-Change in prepaid assets
-118.00%-149.99K
7,134.70%3.62M
-6,909.72%-3.5M
---262.48K
--0
200.00%833.33K
106.00%50K
---50K
--0
--833.33K
-Change in payables and accrued expense
-214.83%-9.8M
-98.35%42.21K
-110.02%-260.24K
-493.66%-9.98M
-52.81%400.65K
801.61%8.54M
169.56%2.55M
--2.6M
--2.54M
--849.06K
-Change in other current liabilities
----
----
--0
--0
--0
----
----
--512
--585
--430
Cash from discontinued investing activities
Operating cash flow
-1,102.61%-16.07M
-574.10%-291.51K
-4,914.13%-4.23M
-10,313.48%-11.27M
74.99%-275.19K
7.34%-1.34M
95.33%-43.25K
21.30%-84.45K
---108.2K
---1.1M
Investing cash flow
Cash flow from continuing investing activities
1,916.65%4.96M
0
0
5.07M
-112.3K
-273.07K
-136.53K
-136.53K
0
0
Net other investing changes
1,916.65%4.96M
--0
--0
--5.07M
---112.3K
---273.07K
---136.53K
----
----
----
Cash from discontinued investing activities
Investing cash flow
1,916.65%4.96M
--0
--0
--5.07M
---112.3K
---273.07K
---136.53K
---136.53K
--0
--0
Financing cash flow
Cash flow from continuing financing activities
12.79M
-270.35K
-84.09K
-6.9M
20.05M
0
0
0
0
0
Net issuance payments of debt
--0
--0
--0
---300K
--300K
--0
--0
--0
--0
--0
Net common stock issuance
---354.44K
---270.35K
----
----
----
--0
----
----
----
----
Net preferred stock issuance
--9.02M
--0
--0
--0
--9.02M
--0
--0
--0
--0
--0
Net other financing activities
--4.13M
--0
--0
---6.6M
--10.73M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--12.79M
---270.35K
---84.09K
---6.9M
--20.05M
--0
--0
--0
--0
--0
Net cash flow
Beginning cash position
-39.36%2.48M
77.79%4.73M
214.11%9.05M
640.87%22.14M
-39.36%2.48M
--4.09M
--2.66M
--2.88M
--2.99M
--4.09M
Current changes in cash
204.79%1.69M
-212.53%-561.86K
-1,854.29%-4.32M
-12,000.24%-13.09M
1,886.80%19.66M
---1.61M
-104.40%-179.78K
---220.99K
---108.2K
---1.1M
End cash Position
68.02%4.17M
68.02%4.17M
77.79%4.73M
214.11%9.05M
640.87%22.14M
-39.36%2.48M
-39.36%2.48M
--2.66M
--2.88M
--2.99M
Free cash flow
-1,102.61%-16.07M
-574.10%-291.51K
-4,914.13%-4.23M
-10,313.48%-11.27M
74.99%-275.19K
7.34%-1.34M
95.33%-43.25K
21.30%-84.45K
---108.2K
---1.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1,102.61%-16.07M-574.10%-291.51K-4,914.13%-4.23M-10,313.48%-11.27M74.99%-275.19K7.34%-1.34M95.33%-43.25K21.30%-84.45K-108.2K-1.1M
Net income from continuing operations 34.21%-7.31M-44.65%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M---2.76M---2.89M
Depreciation and amortization ----------0------------------5.49K--------
Change In working capital -206.22%-9.95M40.73%3.66M-247.72%-3.77M-503.91%-10.25M-76.19%400.65K8,165.20%9.37M2,194.06%2.6M--2.55M--2.54M--1.68M
-Change in prepaid assets -118.00%-149.99K7,134.70%3.62M-6,909.72%-3.5M---262.48K--0200.00%833.33K106.00%50K---50K--0--833.33K
-Change in payables and accrued expense -214.83%-9.8M-98.35%42.21K-110.02%-260.24K-493.66%-9.98M-52.81%400.65K801.61%8.54M169.56%2.55M--2.6M--2.54M--849.06K
-Change in other current liabilities ----------0--0--0----------512--585--430
Cash from discontinued investing activities
Operating cash flow -1,102.61%-16.07M-574.10%-291.51K-4,914.13%-4.23M-10,313.48%-11.27M74.99%-275.19K7.34%-1.34M95.33%-43.25K21.30%-84.45K---108.2K---1.1M
Investing cash flow
Cash flow from continuing investing activities 1,916.65%4.96M005.07M-112.3K-273.07K-136.53K-136.53K00
Net other investing changes 1,916.65%4.96M--0--0--5.07M---112.3K---273.07K---136.53K------------
Cash from discontinued investing activities
Investing cash flow 1,916.65%4.96M--0--0--5.07M---112.3K---273.07K---136.53K---136.53K--0--0
Financing cash flow
Cash flow from continuing financing activities 12.79M-270.35K-84.09K-6.9M20.05M00000
Net issuance payments of debt --0--0--0---300K--300K--0--0--0--0--0
Net common stock issuance ---354.44K---270.35K--------------0----------------
Net preferred stock issuance --9.02M--0--0--0--9.02M--0--0--0--0--0
Net other financing activities --4.13M--0--0---6.6M--10.73M--------------------
Cash from discontinued financing activities
Financing cash flow --12.79M---270.35K---84.09K---6.9M--20.05M--0--0--0--0--0
Net cash flow
Beginning cash position -39.36%2.48M77.79%4.73M214.11%9.05M640.87%22.14M-39.36%2.48M--4.09M--2.66M--2.88M--2.99M--4.09M
Current changes in cash 204.79%1.69M-212.53%-561.86K-1,854.29%-4.32M-12,000.24%-13.09M1,886.80%19.66M---1.61M-104.40%-179.78K---220.99K---108.2K---1.1M
End cash Position 68.02%4.17M68.02%4.17M77.79%4.73M214.11%9.05M640.87%22.14M-39.36%2.48M-39.36%2.48M--2.66M--2.88M--2.99M
Free cash flow -1,102.61%-16.07M-574.10%-291.51K-4,914.13%-4.23M-10,313.48%-11.27M74.99%-275.19K7.34%-1.34M95.33%-43.25K21.30%-84.45K---108.2K---1.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data